![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2366 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Reid, Patrick (PeptiDream 202012 CEO) | Chief Executive Officer (CEO) | PeptiDream Inc. (JP) | Kanto (region) |
| Reimann, Lars (Eurofins 201802 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Eurofins (Group) | Luxembourg (cl=4) |
| Rein, Anne (Strategies & Image 201707 President) | Public Relations Manager / Investor Relations Manager | Strategies & Image SAS | France (region/state unspecified) |
| Reineke, Ulrich (3B Pharmaceuticals 201010 Managing Director) | Managing Director | 3B Pharmaceuticals GmbH (3BP) | Berlin (federal state) |
| Reinhardt, Marc | n. a. | Capgemini (Group) | Baden-Württemberg (federal state) |
| Rémy, Pierre (Keensight Capital 201907 Managing Partner) | Managing Partner | Keensight Capital SAS | Île-de-France (region) |
| Renard, Jean-Marc (MaaT Pharma 2019–2012005 CBO LEFT 6/20) | Chief Business Officer (CBO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Renaud, Jean-Paul (Urania Therapeutics 201911 CSO + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Urania Therapeutics SAS | Grand Est (Great East) (region) |
| Renevot, Anne (Poxel 201704– CFO before EOS Imaging + Cartier + EY) | Chief Financial Officer (CFO) | Poxel (Group) | Auvergne-Rhône-Alpes (region) |
| Renoux, Alain (SGS 201011 General Manager Life Sciences Services Facility in Poitiers) | General Manager (management) | SGS (Group) | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Revah, Frédéric (Généthon 201001– CEO before Sepal Pharma CEO + Cerep) | Chief Executive Officer (CEO) | French Myopathy Association (AFM) | Île-de-France (region) |
| Revenu, Greg (Bryan Garnier 201710– Managing Partner in Paris) | Managing Partner | Bryan, Garnier (Group) | Île-de-France (region) |
| Rey, Sandra (Glowee 201610 CEO + Founder) | Chief Executive Officer (CEO) | Glowee (FR) | Denmark_o |
| Reynaud, François-Henri (Global Bioenergies 201606–201710 CFO LEFT 10/17) | Chief Financial Officer (CFO) | Global Bioenergies (Group) | Île-de-France (region) |
| Reynier, Michaël (Mérieux 201805 VP Healthcare Business – Industrial Microbiology Unit at bioMérieux) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Reynier, Stephan (Cellectis 201512 Chief Regulatory + Compliance Officer) | Regulatory Affairs Manager | Cellectis (Group) | Île-de-France (region) |
| Ribon, Denis (ArchiMed 201609 Founder + Managing Director before 3i 200904 Head European Healthcare) | Managing Partner (investment firm) | ArchiMed (Group) | Auvergne-Rhône-Alpes (region) |
| Riboud, Franck (Danone 200707 CEO) | Chief Executive Officer (CEO) | Danone (Group) | Île-de-France (region) |
| Richard, Jean Philippe (France (govt) 201907 Investment Director of SPI Fund of bpifrance) | Investment Manager | France (govt) | |
| Richard, Louis-François (Air Liquide 202211 Medical Gases Europe Cluster VP) | President/Director/Head Business Group/Unit/Division | Air Liquide (Group) | Île-de-France (region) |
| Richard, Magali (Home Biosciences 202111 Deputy CEO + Co-Founder) | Chief Executive Officer (CEO) | Home Biosciences (Group) | Île-de-France (region) |
| Richardson, Tony (Venn Life Sciences 201302 CEO) | Chief Executive Officer (CEO) | Venn Life Sciences (Group) | Ireland (cl4) |
| Richon, Victoria (Entact Bio 202212 CEO before Ribon Therapeutics + Sanofi + Epizyme + Merck (US) + Aton Pharma) | Chief Executive Officer (CEO) | Entact Bio (US) | Massachusetts (federal state) |
| Richter, Henrijette (Sofinnova Partners 201509 before Novo Group 201304 at Novo Seeds) | Managing Partner (investment firm) | Sofinnova (Group) | Île-de-France (region) |
| Ridder, Ruediger (mtm laboratories –200707– CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Roche (Group) | Baden-Württemberg (federal state) |
| Rideau, Alexis (Deinove 20205– CEO before BIOASTER) | Chief Executive Officer (CEO) | Deinove S.A. (Euronext Growth: ALDEI.PA) | Île-de-France (region) |
| Riester, Franck (France (govt) 202107 Minister Delegate for Foreign Trade and Economic Attractiveness) | Administrative Officer (personnel) | France (govt) | Île-de-France (region) |
| Riff, Joshua (Sanofi 201609– CEO of joint venture Onduo before Optum/UnitedHealth Group) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | Massachusetts (federal state) |
| Rigal, Wendy (Alize RP 201509) | Public Relations Manager / Investor Relations Manager | Alize RP (Public Relations) | Île-de-France (region) |
| Rimbaud, Pierre (Enterome 201203 CMO) | Chief Medical Officer (CMO) | Enterome S.A. | Île-de-France (region) |
| Ringard, Aurélia (Universal Medica Group 201505 Business Developer) | Event Manager / Conference Manager | Universal Medica Group (UMG) (Group) | Île-de-France (region) |
| Riot Lamotte, Laurence (IntegraGen 201110– CFO before Aureus Pharma 200411–20010 CFO) | Chief Financial Officer (CFO) | OncoDNA (Group) | Île-de-France (region) |
| Ririe, Kirk (BioFire Diagnostics 201309 CEO + Founder) | Chief Executive Officer (CEO) | Mérieux (Group) | Utah (federal state) |
| Ritchie, Brian (LifeSci Advisors 201606) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
| Ritsou, Elena (VectorY 202211– COO + BioGeneration Ventures 202211– Venture Partner before GammaDelta Tx + Ipsen) | Chief Operating Officer (COO) | VectorY (Group) | North Holland (province, NL) |
| Ritter, Didier (Skuldtech 201309 CEO) | Chief Executive Officer (CEO) | Acobiom (FR) | Occitanie (Occitania) (region) |
| Rivassou, Jean-François (Kurma Partners 202104– Partner before ISAI Gestion + Adenclassifieds + Banexi Ventures) | Partner (venture partner) | Eurazeo (Group) | Île-de-France (region) |
| Rivet, Sarah (GIE Eurasanté 201709 Business Project Officer) | Business Development Manager / Strategy Manager | GIE Eurasanté | Hauts-de-France (Upper France) (region) |
| Rivière, Anne-Charlotte (Goodwin Procter 202104– Partner at Paris Office before Dechert Paris + Fired Frank) | Attorney / Lawyer | Goodwin Procter (Goowin Law) (Group) | Île-de-France (region) |
| Rizo, Carolina Garcia (Immuneering 202103– CBO before Just Biotherapeutics + Thermo FIsher Scientific + Roche + Cepheid) | Chief Business Officer (CBO) | Immuneering Corporation | Massachusetts (federal state) |
| Robert, Arnaud (Sanofi 202111 EVP + Chief Digital Officer) | Chief Information Officer (CIO) / Chief Digital Officer | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Robert, Franck (Génome Express) | n. a. | Clinical Data (Group) | France (region/state unspecified) |
| Robert, Jonathan (Universal Medica Group 201507 Business Developer) | Event Manager / Conference Manager | Universal Medica Group (UMG) (Group) | Île-de-France (region) |
| Robertson, Clayton (Immunocore 202201 Head of Investor Relations before PureTech Health 202011 Investor Relations) | Public Relations Manager / Investor Relations Manager | PureTech Health (Group) | Greater London (region) |
| Robertson, Neil (Peak Scientific 201710 General Manager EMEA) | General Manager (management) | Peak Scientific (Group) | Scotland |
| Robins, Chad (Adaptive Biotechnologies 201805 CEO + Co-Founder) | Chief Executive Officer (CEO) | Adaptive Biotechnologies (Group) | Washington (federal state) |
| Robinson, James (Jim) (A2 Biotherapeutics 202404– CEO before Sumitomo/Urovant Sciences + Paragon Biosciences + Alkermes) | Chief Executive Officer (CEO) | A2 Biotherapeutics Inc. (A2 Bio) | California (federal state) |
| Rocher, Jean-Philippe (Addex 201802– Co-Head Disovery before Pierre Fabre + Addex + Devgen + GSK Japan + Batelle) | management (personnel) | Addex (Group) | Région Lémanique (region) |
| Rocheteau, Pierre (Olgram 202401 CEO + Co-Founder) | Chief Executive Officer (CEO) | Olgram SAS | France (region/state unspecified) |
| Rochlin, Kate (Nanobiotix 201905– Director of Business Development at Curadigm) | Business Development Manager / Strategy Manager | Nanobiotix (Group) | |
| Rock-Archer, Hillary (Andrew Lloyd & Associates 201509) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | South East England (region) |
| Rodriguez, Alicia (Agilent 201506 VP Finance + Investor Relations) | Public Relations Manager / Investor Relations Manager | Agilent (Group) | California (federal state) |
| Rodriguez, Laurence (GenSight Biologics 202312– CEO joined 5/21 as Head of Operations France before Sanofi Genzyme) | Chief Executive Officer (CEO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
| Roe, Matthew (Crescendo Biologics 201106– CBO before Genzyme for 23 years) | Chief Business Officer (CBO) | Crescendo Biologics Ltd. | East of England (region) |
| Rohayem, Jacques (Riboxx 201602 CEO + CSO) | Managing Director | Riboxx GmbH (Riboxx Pharmaceuticals) | Sachsen (federal state) |
| Rohou, Anne (Genopole 201709 Communications Department) | Public Relations Manager / Investor Relations Manager | Genopole (GIP Genopole) | Île-de-France (region) |
| Rolfs, Arndt (Centogene 201406–202010 CEO + Founder before Univ Rostock Prof RESIGNED 10/20) | Managing Director | Centogene (Group) | Mecklenburg-Vorpommern (federal state) |
| Rolland, Olivier (Toulouse White Biotechnology 202204 Executive Director) | President/Director/Head of Research Organisation/Unit | INRA (Institut National de la Recherche Agronomique) (FR) | Occitanie (Occitania) (region) |
| Roman, Eric (GE Healthcare 200704 General Manager Genomic Sciences business) | General Manager (management) | General Electric (Group) | South East England (region) |
| Roman, Francois J. (Amylgen 201510 Head Business Development + Co-Founder before Euroscreen + Pfizer) | Business Development Manager / Strategy Manager | Amylgen SAS | Occitanie (Occitania) (region) |
| Romano, Fabrice (Keranova 2015– CEO + Founder before EyeTechCare Founder + CEO) | Chief Executive Officer (CEO) | Keranova S.A. | France (region/state unspecified) |
| Romanos, Mike (Microbiotica 201612– CEO + Co-Founder before Crescendo Biologics CEO before CSO before GSK) | Chief Executive Officer (CEO) | Microbiotica Ltd. | East of England (region) |
| Ronin, Hervé (Bryan, Garnier 201710 Partner in Paris) | management (personnel) | Bryan, Garnier (Group) | Île-de-France (region) |
| Rooney, Terry (RooneyPartners 201702 CEO + Founder) | Chief Executive Officer (CEO) | RooneyPartners (Rooney & Associates) | New York (federal state) |
| Roques, Stéphane (Medicen Paris Region 201806– CEO) | Chief Executive Officer (CEO) | Medicen Paris Region | Île-de-France (region) |
| Roquet Montégon, Tristan (NewCap 201707) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Rosat, Jean-Pierre (Aleva Neurotherapeutics 201108 CEO) | Chief Executive Officer (CEO) | Aleva Neurotherapeutics S.A. | Région Lémanique (region) |
| Rose, Dan (LimFlow 201804 CEO) | Chief Executive Officer (CEO) | Inari Medical (Group) | Île-de-France (region) |
| Rosenberg, Rudolph (Excelya 202103– CFO zuvor Groupe Allo-Media + Nibelis + Dell Technologies) | Chief Financial Officer (CFO) | Excelya (Group) | Île-de-France (region) |
| Rosenberg, Tony (MPM Capital 201711 Managing Director before Novartis + Sandoz) | Managing Director | MPM Capital (Group) | Massachusetts (federal state) |
| Rosenthal, Felicia (CellGenix 200501 Managing Director before Metreon Bioproducts 1996– BIO Deutschland 200501) | Managing Director | Sartorius (Group) | Baden-Württemberg (federal state) |
| Rossetti, Luciano (Flagship Pioneering 202101– CMO + Head RnD of Pioneering Medicines before Merck (DE) + Merck (US)) | Chief Medical Officer (CMO) | Flagship Pioneering | Massachusetts (federal state) |
| Rossignol, Jacques (Techlife Capital 202209 Managing Partner) | Managing Partner | Techlife Capital (Group) | France (region/state unspecified) |
| Rossignol, Karine (Smart Immune 202206 CEO + Co-Founder) | Chief Executive Officer (CEO) | Smart Immune SAS | Île-de-France (region) |
| Roth, Lee (Ruth Group 201610) | Public Relations Manager / Investor Relations Manager | Ruth Group, The (TRG) | New York (federal state) |
| Rothman, Martin T. (Sofinnova 201805– Venture Partner at Sofinnova Ventures before LimFlow + Medtronic) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Rottmann, Martin (Univ Versailles 201012 Associate Professor + Hospital Raymond Ponicaré, Garches) | Assistant Professor / Associate Professor | University of Versailles-Saint-Quentin-en-Yvelines (UVSQ) | Île-de-France (region) |
| Roucoules, Valérie (Pierre Fabre 201805 Media Relations) | Public Relations Manager / Investor Relations Manager | Pierre Fabre (Group) | Île-de-France (region) |
| Rougemond, Eric (Aguettant 201302– CEO) | Chief Executive Officer (CEO) | Aguettant (Group) | Auvergne-Rhône-Alpes (region) |
| Rougier, Marc (Elaia Partners 202201 Partner) | Partner (venture partner) | Elaia Partners (Group) | Île-de-France (region) |
| Rouillé, Arthur (NewCap 202110) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Roulon, Thibaut (France (govt) 201509 Investment Director at InnoBio) | Investment Manager | France (govt) | Île-de-France (region) |
| Roulstone, Ian (Scientific Laboratory Supplies 201607 Sales Director) | Sales Manager / Marketing Manager | Dutscher (DD) (Group) | Yorkshire and the Humber (region) |
| Rousseau, Philippe (Pherecydes Pharma 202101 CFO formerly ExonHit 200801–200906 CFO) | Chief Operating Officer (COO) | Pherecydes Pharma S.A. (Euronext Paris: ALPHE) | Île-de-France (region) |
| Rousseaux, Pascal (Processium 202204 CEO) | Chief Executive Officer (CEO) | Processium (Group) | Auvergne-Rhône-Alpes (region) |
| Rousselle, Tristan (Protein’eXpert 200011–201306 CEO + Co-Founder LEFT 6/13 before Genome Express) | Chief Executive Officer (CEO) | Aguettant (Group) | Auvergne-Rhône-Alpes (region) |
| Rousselot, Morgane (SeaBeLife 202203 CEO + Co-Founder) | Chief Executive Officer (CEO) | SeaBeLife SAS | Bretagne (Britanny) (region) |
| Rouxel, Laetitia (Evotec 202304– CFO before Wavin + Coty + Danone + JnJ + Pfizer) | Chief Financial Officer (CFO) | Evotec (Group) | Hamburg (federal state) |
| Rowlen, Kathy (InDevR 202301 CEO + Co-Founder) | Chief Executive Officer (CEO) | InDevR Inc. | Colorado (federal state) |
| Roychowdhury, Debasish (Sanofi-Aventis 201006 SVP Global Oncology) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Ruban, Charles (DBV Technologies 201709 Chief Commercial Officer before Chief Development Officer) | Chief Commercial Officer (CCO) | DBV Technologies S.A. (Euronext Paris: DBV + Nasdaq Global Select Market: DBVT) | Île-de-France (region) |
| Ruiz, Stéphane (Actifin 201803) | Public Relations Manager / Investor Relations Manager | Actifin (FR) | Île-de-France (region) |
| Rulleau, Laurence (CTI Life Sciences 202205 Managing Partner) | Managing Partner (investment firm) | CTI Life Sciences Fund L.P. | Québec |
| Rummelt, Andreas (InterPharmaLink 202011 CEO + Partner before Novartis + Sandoz) | Chief Executive Officer (CEO) | InterPharmaLink AG | Northwestern Switzerland (region) |
| Rusckowski, Steve (Quest Diagnostics 201205– CEO before Philips CEO of Philips Healthcare sector since 2006) | Chief Executive Officer (CEO) | Quest Diagnostics (Group) | New Jersey (federal state) |
| Russo, Tony (Russo Partners 201701) | Public Relations Manager / Investor Relations Manager | Russo Partners LLC | New York (federal state) |
| Rutt, Antony (KDBio SAS 201704 President + Founder) | President/Director/Head Business Group/Unit/Division | KDBio SAS | Alsace (Elsass) (region) [before 2015] |
| Rübsamen-Schaeff, Helga (AiCuris 200603– before Bayer HealthCare anti-infectives research) | Chief Executive Officer (CEO) | STRÜNGMANN Group (family Strüngmann) | Nordrhein-Westfalen (federal state) |
| Ryckebusch, Sylvie (Domain Therapeutics 202205 Non-executive Board Member) | Board member, non-executive | Domain Therapeutics (Group) | Grand Est (Great East) (region) |
| Rüdiger, Niels S. (AH Diagnostics 202304– Board Chair + CVO for Business Development before CEO) | Board member (all kinds of boards: supervisory, advisory, management etc.) | Dutscher (DD) (Group) | Denmark_o |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
